667 related articles for article (PubMed ID: 2898362)
1. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
[TBL] [Abstract][Full Text] [Related]
2. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
Spinedi E; Johnston C; Negro-Vilar A
Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
[TBL] [Abstract][Full Text] [Related]
3. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
Samson WK; Aguila MC; Bianchi R
Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
Katakami H; Downs TR; Frohman LA
Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
[TBL] [Abstract][Full Text] [Related]
6. Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types.
Schwaninger M; Knepel W; Döhler KD; Sandow J
Endocrinology; 1987 Jul; 121(1):167-74. PubMed ID: 2885174
[TBL] [Abstract][Full Text] [Related]
7. Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
Knepel W; Schwaninger M; Wesemeyer G; Döhler KD; Sandow J
Endocrinology; 1987 Feb; 120(2):732-8. PubMed ID: 2879724
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
Aguila MC; McCann SM
Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
[TBL] [Abstract][Full Text] [Related]
9. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
Soya H; Suzuki M
Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
[TBL] [Abstract][Full Text] [Related]
10. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
11. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
13. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
Sahu A; Xu B; Kalra SP
Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro.
Camoratto AM; Grandison L
Endocrinology; 1989 Mar; 124(3):1502-6. PubMed ID: 2917522
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
Kentroti S; Aguila MC; McCann SM
Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283
[TBL] [Abstract][Full Text] [Related]
16. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
17. The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels.
Köves K; Kántor O; Molnár J; Heinzlmann A; Szabó E; Szabó F; Nemeskéri A; Horváth J; Arimura A
J Mol Neurosci; 2003 Apr; 20(2):141-52. PubMed ID: 12794308
[TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of alpha-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence.
Ojeda SR; Negro-Vilar A; McCann SM
Endocrinology; 1982 Feb; 110(2):409-12. PubMed ID: 6276133
[TBL] [Abstract][Full Text] [Related]
19. Regulation of luteinizing hormone secretion by neuropeptide Y in rats: hypothalamic and pituitary actions.
Crowley WR; Kalra SP
Synapse; 1988; 2(3):276-81. PubMed ID: 3062832
[TBL] [Abstract][Full Text] [Related]
20. Modulation of somatostatin binding to rat pituitary membranes by exogenously administered growth hormone.
Katakami H; Berelowitz M; Marbach M; Frohman LA
Endocrinology; 1985 Aug; 117(2):557-60. PubMed ID: 2862011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
